HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B)

Clinical trials for HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B) explained in plain language.

Never miss a new study

Get alerted when new HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B) trials appear

Sign up with your email to follow new studies for HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New liver study tests drug safety in patients with mild to moderate impairment

Knowledge-focused Not yet recruiting

This early-stage study looks at how a single dose of the drug MDR-001 is handled by the body in people with mild or moderate liver impairment compared to healthy volunteers. About 32 participants will take one tablet, and researchers will measure drug levels in the blood and moni…

Matched conditions: HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B)

Phase: PHASE1 • Sponsor: MindRank AI Ltd • Aim: Knowledge-focused

Last updated May 26, 2026 10:25 UTC

HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B)

Get alerted when new HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B) trials appear

New liver study tests drug safety in patients with mild to moderate impairment